Kynam Capital Management, LP Celldex Therapeutics, Inc. Call Options Transaction History
Kynam Capital Management, LP
- $1.22 Billion
- Q3 2024
Call Options
1 transactions
Others Institutions Holding CLDX
# of Institutions
207Shares Held
67.3MCall Options Held
1.69MPut Options Held
980K-
Wellington Management Group LLP Boston, MA9.24MShares$241 Million0.06% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$122 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.87MShares$101 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$86.8 Million1.99% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.07MShares$80 Million1.76% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.22B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...